Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development

S Ezzikouri, J Nourlil, S Benjelloun… - Human vaccines & …, 2020 - Taylor & Francis
ABSTRACT The current Coronavirus Disease 2019 (COVID-19) pandemic is causing great
alarm around the world. The pathogen for COVID-19–severe acute respiratory syndrome …

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2/COVID-19 pandemic

SB Barbuddhe, DB Rawool, PP Gaonkar… - Human Vaccines & …, 2020 - Taylor & Francis
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the etiological agent of
the novel coronavirus disease (COVID-19), has posed a great public health threat to the …

Recent insights into emerging coronavirus: SARS-CoV-2

Z Shang, SY Chan, WJ Liu, P Li… - ACS infectious …, 2020 - ACS Publications
The SARS-CoV-2 outbreak that emerged at the end of 2019 has affected more than 58
million people with more than 1.38 million deaths and has had an incalculable impact on the …

[图书][B] Coronavirus disease 2019 (COVID-19): epidemiology, pathogenesis, diagnosis, and therapeutics

SK Saxena - 2020 - books.google.com
This book provides a comprehensive overview of recent novel coronavirus (SARS-CoV-2)
infection, their biology and associated challenges for their treatment and prevention of novel …

SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight …

C Chakraborty, M Bhattacharya, K Dhama - Vaccines, 2023 - mdpi.com
We are currently approaching three years since the beginning of the coronavirus disease
2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday …

SARS-CoV-2: emergence of new variants and effectiveness of vaccines

DD Singh, A Parveen, DK Yadav - Frontiers in cellular and infection …, 2021 - frontiersin.org
The emergence of SARS-CoV-2 variants may cause resistance at the immunity level against
current vaccines. Some emergent new variants have increased transmissibility, infectivity …

[HTML][HTML] Global trends in COVID-19

CM Zhou, XR Qin, LN Yan, Y Jiang, XJ Yu - Infectious Medicine, 2022 - Elsevier
The pandemic COVID-19 is certainly one of the most severe infectious diseases in human
history. In the last 2 years, the COVID-19 pandemic has caused over 418.6 million confirmed …

[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …

SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic

AA Rabaan, SH Al-Ahmed, R Sah, R Tiwari… - Annals of Clinical …, 2020 - Springer
A novel coronavirus (SARS-CoV-2), causing an emerging coronavirus disease (COVID-19),
first detected in Wuhan City, Hubei Province, China, which has taken a catastrophic turn with …

[HTML][HTML] Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)

DG Ahn, HJ Shin, MH Kim, S Lee, HS Kim… - … of microbiology and …, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), which causes serious respiratory illness
such as pneumonia and lung failure, was first reported in Wuhan, the capital of Hubei …